According to a new report by Polaris Market Research, the global narcolepsy therapeutics market was valued at USD 3,819.10 million in 2024 and is projected to reach USD 7,852.93 million by 2034, expanding at a CAGR of 7.5% over the forecast period. Growth is underpinned by rising narcolepsy diagnosis rates, expanding drug-development pipelines, and accelerating orexin receptor agonist...